Publicaciones en las que colabora con Sara García Alonso (8)

2022

  1. mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer

    Molecular Cancer Research, Vol. 20, Núm. 7, pp. 1108-1121

2021

  1. Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2018

  1. Refining Early Antitumoral Drug Development

    Trends in Pharmacological Sciences

  2. Resistance to antibody–drug conjugates

    Cancer Research, Vol. 78, Núm. 9, pp. 2159-2165

2017

  1. Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer

    Clinical Cancer Research, Vol. 23, Núm. 22, pp. 7006-7019

  2. Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity

    Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651

2016

  1. Multisite phosphorylation of P-Rex1 by protein kinase C

    Oncotarget, Vol. 7, Núm. 47, pp. 77937-77949

2015

  1. Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling

    Oncotarget, Vol. 6, Núm. 30, pp. 30057-30071